Inventabio Review
114
Fast Facts
Contact Info and Support
Traffic information
| Category | Metrics | Meaning |
|---|---|---|
| Ratings | Global Rank | - |
| Country Code | - | |
| Country Rank | - | |
| Category Rank | - | |
| Engagement metrics | Visits | 0 |
| Bounce Rate | 0 | |
| Pageviews per Visit | 0 | |
| Avg. Visit Duration | 0 | |
| Estimated monthly visits | December 2025 | 0 |
| January 2026 | 0 | |
| February 2026 | 0 | |
| Traffic sources | Social | - |
| Paid Referrals | - | |
| - | ||
| Referrals | - | |
| Search | - | |
| Direct | - |
About Inventabio
Inventabio is not regulated by any recognized financial authority. It claims to hold supervision from ASIC, DFSA, FSCA, FCA, CySEC, Belize FSC, and Mauritius FSC, but searches in official registries of these regulators returned no record of licensure. The UK’s Financial Conduct Authority issued a warning on April 20, 2023, stating that Inventabio is an unauthorized firm offering financial services in the UK without permission. The FCA listed Inventabio as an unauthorized broker and warned consumers against engaging with it. These findings confirm the absence of any valid license or regulatory oversight.
Inventabio reportedly offers forex, cryptocurrencies, and precious metals trading with features such as 0.1‑pip spreads, 20:1 leverage across all asset classes, and no minimum deposit disclosed. However, these figures cannot be verified through official sources, and the broker does not appear in any securities or regulatory databases to substantiate such offerings.
Pros and cons
Cons
- Unregulated and unauthorized to provide financial services—subject of an FCA warning listing it as an unauthorized firm (FCA resolution April 20, 2023).
- Regulatory claims are false, as confirmed by searches of ASIC, DFSA, FSCA, FCA, CySEC, Belize FSC, and Mauritius FSC registers.
- Transparency issues: trading terms (leverage, spreads, deposit conditions) are not verifiable through official documentation.
